Syneos Health, Inc. appointed Michael Bonello as the Chief Financial Officer of the Company, effective July 1, 2023, succeeding Stanford (Ben) Rudnick as the Company's principal financial officer as of such date. Prior to his appointment, Mr. Bonello, 53, served as the Chief Financial Officer of Clario, Inc. a leading clinical trial data collection company, from November 2021 to present. Prior to that role, from May 2018 to August 2021, he served as Executive Vice President and Chief Financial Officer of PRA Health Sciences, Inc., a former contract research organization that was acquired by ICON plc in 2021.

Mr. Bonello previously served as Senior Vice President, Accounting and Corporate Controller for PRA, after having joined the company in March 2008. Prior to PRA, Mr. Bonello held positions with Cree, Inc., where he was Director of Finance/Corporate Controller, and Genworth Financial (formerly GE Mortgage Insurance Corporation) where he served as Vice President, Domestic Controller and Global Reporting Leader. Mr. Bonello also served for seven years in the audit practice at PricewaterhouseCoopers LLP.

He received a Bachelor of Business Administration with a concentration in accounting from St. Bonaventure University.